Onbrez
Dry Powder Inhalation Capsule (DPI)
Generic Name
Indacaterol Maleate
Manufacturer
Nevian Lifescience PLC
Unit Price
Unit Price: ৳ 93.50 (3 x 10: ৳ 2,805.00) Strip Price: ৳ 935.00
🔹 Indications
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
🔹 Dosage & Administration
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
🔹 Interaction
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
🔹 Contraindications
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
🔹 Side Effects
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
🔹 Pregnancy & Lactation
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
🔹 Precautions & Warnings
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
🔹 Storage Conditions
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
💡 Frequently Asked Questions
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Onbrez is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
User Reviews
⭐
No reviews yet!
Be the first to share your experience.